Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
Diseases
10970 results
-
SPAP public summary documents – April 2022 – Omnigon Post-Op AMPatch Stoma Cover
This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to reject listing the Omnigon Post-Op AMPatch Stoma Cover in subgroup 9(m) of the Stoma Appliance Scheme (SAS) Schedule. -
SPAP public summary documents – April 2022 – Omnigon BBraun Flexima Active
This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 6 products from the current product range of Omnigon BBraun Flexima Active (SAS Code 80165F) in subgroup 3(b) of the Stoma Appliance Scheme (SAS) Schedule. -
SPAP public summary documents – April 2022 – ConvaTec Sur-Fit Natura Urostomy Pouch
This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Sur-Fit Natura Urostomy Pouch in subgroup 7(a) of the Stoma Appliance Scheme (SAS) Schedule. -
SPAP public summary documents – April 2022 – ConvaTec Sur-Fit Natura Urostomy Pouch
This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Sur-Fit Natura Urostomy Pouch in subgroup 7(a) of the Stoma Appliance Scheme (SAS) Schedule. -
SPAP public summary documents – April 2022 – Omnigon BBraun Flexima Active
This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 6 products from the current product range of Omnigon BBraun Flexima Active (SAS Code 80165F) in subgroup 3(b) of the Stoma Appliance Scheme (SAS) Schedule. -
SPAP public summary documents – April 2022 – Omnigon BBraun Flexima Active – SAS Code 80142B
This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 6 variants in the existing product range of Omnigon BBraun Flexima Active (SAS Code 80142B) in subgroup 2(b) of the Stoma Appliance Scheme (SAS) Schedule. -
SPAP public summary document – April 2022 – Omnigon F3 AMPatch Stoma Cover
This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to reject listing the Omnigon F3 AMPatch Stoma Cover in subgroup 9(m) of the Stoma Appliance Scheme (SAS) Schedule. -
National Notifiable Diseases Surveillance System (NNDSS) fortnightly reports – 27 June to 10 July 2022
This report, and accompanying table, provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 27 June to 10 July 2022. -
COVID-19 outbreaks in Australian residential aged care facilities – 22 July 2022
This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services. -
Perfluorinated chemicals in food
This collection contains Food Standards Australia New Zealand’s (FSANZ) report on perfluorinated chemicals in food, Plain English summaries, frequently asked questions and supporting documents. -
Certification statement – COVID-19 Campaign – COVID-19 treatments
This certification statement, signed by Secretary Brendan Murphy on 15 July 2022, certifies that the COVID-19 campaign complies with relevant guidelines and policies. -
SPAP public summary documents – April 2022 – ConvaTec Natura Durahesive Skin Barrier
This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Natura Durahesive Skin Barrier in subgroup 4(a) of the Stoma Appliance Scheme (SAS) Schedule. -
SPAP public summary documents – April 2022 – ConvaTec Natura Two-Piece Drainable Pouch
This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Natura Two-Piece Drainable Pouch in subgroup 6(a) of the Stoma Appliance Scheme (SAS) Schedule. -
Practitioner Review Program – Frequently asked questions
Frequently asked questions about the Practitioner Review Program. -
SPAP public summary documents – April 2022 – ConvaTec Sur-Fit Natura Urostomy Pouch
This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Sur-Fit Natura Urostomy Pouch in subgroup 7(a) of the Stoma Appliance Scheme (SAS) Schedule. -
SPAP public summary documents – April 2022 – Omnigon BBraun Flexima Active
This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list the Omnigon BBraun Flexima Active in subgroup 2(b) of the Stoma Appliance Scheme (SAS) Schedule. -
Prescribed pattern of services – How breaches are detected and what happens next?
Information about how a breach of the prescribed pattern of services (the 80/20 and 30/20 rules) is detected and the next steps when an 80/20 or 30/20 breach is found. -
Prescribed pattern of services – The 80/20 and 30/20 rules
This collection provides information for practitioners about the prescribed pattern of Service (the 80/20 and 30/20 rules). -
PRP for practitioners
This collection provides information about the Practitioner Review Program and how it is applied to practitioners. -
Inappropriate practice
Information on the definition of inappropriate practice and how it applies to practitioners and corporate entities. -
Common compliance issues associated with findings of inappropriate practice
Information on the common compliance issues associated with inappropriate practice based on Professional Services Review outcomes. -
What can I do to avoid practicing inappropriately?
Information on how to avoid practicing inappropriately, your responsibilities and sources of information to meet Medicare requirements. -
PRP for practitioners – The interview
Information about the Practitioner Review Program (PRP) interview -
PRP for practitioners – The 6-month review
Information about the Practitioner Review Program (PRP) 6-month period of review. -
PRP for practitioners – Referral to the delegate without a 6-month review
Information about the Practitioner Review Program (PRP) where practitioners are referred to a delegate of the Chief Executive Medicare (delegate) after an interview without a six-month period of review.